Biotech · Private company · Athens, GA, US
Lectenz Bio, Inc.
Track this companyFree. Adds Lectenz Bio, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards6
- Innovative glycan-specific reagents to accelerate the detection of disease biomarkersFiscal year 2026 · $1MNIH RePORTER 4R44GM159548-02 · fetched Nov 12, 2026
- Innovative glycan-specific reagents to accelerate the detection of disease biomarkersFiscal year 2025 · $313.8KNIH RePORTER 1R44GM159548-01 · fetched Nov 12, 2026
- Engineered Pan-Specific Reagents for N-Glycan Detection and EnrichmentFiscal year 2025 · $1MNIH RePORTER 5R44OD035390-03 · fetched Nov 12, 2026
- A new approach to monitoring glycosylation during glycoprotein productionFiscal year 2024 · $34.7KNIH RePORTER 3R44GM153145-01S1 · fetched Nov 12, 2026
- Engineered Pan-Specific Reagents for N-Glycan Detection and EnrichmentFiscal year 2024 · $1MNIH RePORTER 4R44OD035390-02 · fetched Nov 12, 2026
- A new approach to monitoring glycosylation during glycoprotein productionFiscal year 2024 · $984.2KNIH RePORTER 5R44GM153145-02 · fetched Nov 12, 2026